| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 458 | 462 | 638 | 514 | 464 | 492 | 648 | 473 | 465 | 585 | 668 | 572 | |
Growth YoY Revenue Growth YoY% | 11.9 | 6.3 | 19.0 | 5.7 | 1.3 | 6.5 | 1.6 | -7.9 | 0.1 | 18.9 | 3.0 | 20.9 |
| 374 | 406 | 492 | 444 | 417 | 438 | 508 | 439 | 412 | 478 | 525 | 508 | |
| 84 | 56 | 147 | 70 | 47 | 54 | 140 | 34 | 52 | 106 | 143 | 64 | |
OPM OPM% | 18.3 | 12.2 | 23.0 | 13.7 | 10.1 | 11.0 | 21.6 | 7.2 | 11.3 | 18.2 | 21.4 | 11.2 |
| 25 | 20 | 28 | 35 | 19 | 16 | 36 | 21 | 0 | 50 | 48 | 18 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Depreciation DepreciationCr | 10 | 10 | 11 | 14 | 13 | 16 | 15 | 15 | 15 | 14 | 15 | 16 |
PBT PBTCr | 98 | 65 | 163 | 90 | 51 | 53 | 160 | 38 | 36 | 140 | 175 | 65 |
| 18 | 19 | 44 | 18 | 14 | 15 | 38 | 10 | 8 | 37 | 42 | 16 | |
| 79 | 46 | 119 | 72 | 37 | 39 | 121 | 28 | 28 | 103 | 132 | 49 | |
Growth YoY PAT Growth YoY% | 94.5 | 51.0 | 8.4 | 3.2 | -53.2 | -16.4 | 1.9 | -60.6 | -23.6 | 167.4 | 9.2 | 72.9 |
NPM NPM% | 17.3 | 10.0 | 18.6 | 14.0 | 8.0 | 7.9 | 18.7 | 6.0 | 6.1 | 17.7 | 19.8 | 8.6 |
| 4.9 | 2.8 | 7.3 | 4.4 | 2.3 | 2.4 | 7.5 | 1.8 | 1.7 | 6.3 | 8.1 | 3.0 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 458 | 462 | 638 | 514 | 464 | 492 | 648 | 473 | 465 | 585 | 668 | 572 | |
Growth YoY Revenue Growth YoY% | 11.9 | 6.3 | 19.0 | 5.7 | 1.3 | 6.5 | 1.6 | -7.9 | 0.1 | 18.9 | 3.0 | 20.9 |
| 374 | 406 | 492 | 444 | 417 | 438 | 508 | 439 | 412 | 478 | 525 | 508 | |
| 84 | 56 | 147 | 70 | 47 | 54 | 140 | 34 | 52 | 106 | 143 | 64 | |
OPM OPM% | 18.3 | 12.2 | 23.0 | 13.7 | 10.1 | 11.0 | 21.6 | 7.2 | 11.3 | 18.2 | 21.4 | 11.2 |
| 25 | 20 | 28 | 35 | 19 | 16 | 36 | 21 | 0 | 50 | 48 | 18 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Depreciation DepreciationCr | 10 | 10 | 11 | 14 | 13 | 16 | 15 | 15 | 15 | 14 | 15 | 16 |
PBT PBTCr | 98 | 65 | 163 | 90 | 51 | 53 | 160 | 38 | 36 | 140 | 175 | 65 |
| 18 | 19 | 44 | 18 | 14 | 15 | 38 | 10 | 8 | 37 | 42 | 16 | |
| 79 | 46 | 119 | 72 | 37 | 39 | 121 | 28 | 28 | 103 | 132 | 49 | |
Growth YoY PAT Growth YoY% | 94.5 | 51.0 | 8.4 | 3.2 | -53.2 | -16.4 | 1.9 | -60.6 | -23.6 | 167.4 | 9.2 | 72.9 |
NPM NPM% | 17.3 | 10.0 | 18.6 | 14.0 | 8.0 | 7.9 | 18.7 | 6.0 | 6.1 | 17.7 | 19.8 | 8.6 |
| 4.9 | 2.8 | 7.3 | 4.4 | 2.3 | 2.4 | 7.5 | 1.8 | 1.7 | 6.3 | 8.1 | 3.0 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 994 | 1,014 | 1,075 | 1,091 | 1,344 | 1,333 | 1,528 | 1,784 | 1,943 | 2,108 | 2,171 | 2,289 |
Growth Revenue Growth% | 11.8 | 2.0 | 6.0 | 1.4 | 23.2 | -0.8 | 14.6 | 16.7 | 8.9 | 8.5 | 3.0 | 10.2 |
| 766 | 770 | 848 | 860 | 1,051 | 999 | 1,274 | 1,533 | 1,604 | 1,783 | 1,825 | 1,923 | |
| 229 | 243 | 227 | 231 | 293 | 334 | 254 | 251 | 339 | 325 | 346 | 366 | |
OPM OPM% | 23.0 | 24.0 | 21.1 | 21.2 | 21.8 | 25.1 | 16.6 | 14.1 | 17.4 | 15.4 | 15.9 | 16.0 |
| 39 | 44 | 50 | 40 | 68 | 95 | 76 | 50 | 102 | 91 | 93 | 116 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 4 |
Depreciation DepreciationCr | 34 | 35 | 35 | 33 | 37 | 38 | 37 | 39 | 40 | 54 | 59 | 60 |
PBT PBTCr | 232 | 252 | 241 | 237 | 320 | 388 | 289 | 258 | 396 | 357 | 375 | 417 |
| 63 | 63 | 67 | 67 | 80 | 87 | 73 | 64 | 91 | 90 | 93 | 104 | |
PAT PATCr | 169 | 189 | 174 | 170 | 240 | 301 | 216 | 194 | 305 | 267 | 281 | 313 |
Growth PAT Growth% | 13.9 | 11.8 | -8.0 | -2.1 | 41.3 | 25.6 | -28.2 | -10.3 | 57.4 | -12.6 | 5.5 | 39.0 |
NPM NPM% | 17.0 | 18.6 | 16.1 | 15.6 | 17.9 | 22.6 | 14.2 | 10.9 | 15.7 | 12.7 | 13.0 | 13.7 |
| 8.8 | 10.6 | 9.8 | 9.7 | 13.9 | 17.7 | 12.8 | 11.7 | 18.6 | 16.4 | 17.3 | 19.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 994 | 1,014 | 1,075 | 1,091 | 1,344 | 1,333 | 1,528 | 1,784 | 1,943 | 2,108 | 2,171 | 2,289 |
Growth Revenue Growth% | 11.8 | 2.0 | 6.0 | 1.4 | 23.2 | -0.8 | 14.6 | 16.7 | 8.9 | 8.5 | 3.0 | 10.2 |
| 766 | 770 | 848 | 860 | 1,051 | 999 | 1,274 | 1,533 | 1,604 | 1,783 | 1,825 | 1,923 | |
| 229 | 243 | 227 | 231 | 293 | 334 | 254 | 251 | 339 | 325 | 346 | 366 | |
OPM OPM% | 23.0 | 24.0 | 21.1 | 21.2 | 21.8 | 25.1 | 16.6 | 14.1 | 17.4 | 15.4 | 15.9 | 16.0 |
| 39 | 44 | 50 | 40 | 68 | 95 | 76 | 50 | 102 | 91 | 93 | 116 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 4 |
Depreciation DepreciationCr | 34 | 35 | 35 | 33 | 37 | 38 | 37 | 39 | 40 | 54 | 59 | 60 |
PBT PBTCr | 232 | 252 | 241 | 237 | 320 | 388 | 289 | 258 | 396 | 357 | 375 | 417 |
| 63 | 63 | 67 | 67 | 80 | 87 | 73 | 64 | 91 | 90 | 93 | 104 | |
PAT PATCr | 169 | 189 | 174 | 170 | 240 | 301 | 216 | 194 | 305 | 267 | 281 | 313 |
Growth PAT Growth% | 13.9 | 11.8 | -8.0 | -2.1 | 41.3 | 25.6 | -28.2 | -10.3 | 57.4 | -12.6 | 5.5 | 39.0 |
NPM NPM% | 17.0 | 18.6 | 16.1 | 15.6 | 17.9 | 22.6 | 14.2 | 10.9 | 15.7 | 12.7 | 13.0 | 13.7 |
| 8.8 | 10.6 | 9.8 | 9.7 | 13.9 | 17.7 | 12.8 | 11.7 | 18.6 | 16.4 | 17.3 | 19.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 18 | 18 | 18 | 18 | 17 | 17 | 17 | 17 | 16 | 16 | 16 | 16 |
Reserves ReservesCr | 1,065 | 1,252 | 1,259 | 1,428 | 1,530 | 1,717 | 1,940 | 1,965 | 2,081 | 2,265 | 2,469 | 2,653 |
| 163 | 179 | 211 | 179 | 246 | 203 | 272 | 312 | 311 | 362 | 364 | 434 | |
| 20 | 18 | 18 | 16 | 19 | 19 | 42 | 50 | 60 | 71 | 70 | 73 | |
| 1,266 | 1,468 | 1,505 | 1,640 | 1,813 | 1,956 | 2,270 | 2,343 | 2,468 | 2,714 | 2,919 | 3,176 | |
| 523 | 708 | 722 | 740 | 927 | 934 | 1,000 | 1,025 | 1,066 | 1,089 | 1,133 | 1,197 | |
| 742 | 760 | 783 | 900 | 886 | 1,022 | 1,270 | 1,318 | 1,402 | 1,625 | 1,786 | 1,979 | |
| 1,266 | 1,468 | 1,505 | 1,640 | 1,813 | 1,956 | 2,270 | 2,343 | 2,468 | 2,714 | 2,919 | 3,176 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 18 | 18 | 18 | 18 | 17 | 17 | 17 | 17 | 16 | 16 | 16 | 16 |
Reserves ReservesCr | 1,065 | 1,252 | 1,259 | 1,428 | 1,530 | 1,717 | 1,940 | 1,965 | 2,081 | 2,265 | 2,469 | 2,653 |
| 163 | 179 | 211 | 179 | 246 | 203 | 272 | 312 | 311 | 362 | 364 | 434 | |
| 20 | 18 | 18 | 16 | 19 | 19 | 42 | 50 | 60 | 71 | 70 | 73 | |
| 1,266 | 1,468 | 1,505 | 1,640 | 1,813 | 1,956 | 2,270 | 2,343 | 2,468 | 2,714 | 2,919 | 3,176 | |
| 523 | 708 | 722 | 740 | 927 | 934 | 1,000 | 1,025 | 1,066 | 1,089 | 1,133 | 1,197 | |
| 742 | 760 | 783 | 900 | 886 | 1,022 | 1,270 | 1,318 | 1,402 | 1,625 | 1,786 | 1,979 | |
| 1,266 | 1,468 | 1,505 | 1,640 | 1,813 | 1,956 | 2,270 | 2,343 | 2,468 | 2,714 | 2,919 | 3,176 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 174 | 154 | 150 | 112 | 250 | 207 | 162 | 155 | 221 | 318 | 200 | |
| -73 | -144 | 20 | -120 | -98 | -77 | -145 | 11 | -17 | -200 | -110 | |
| -97 | 0 | -169 | 0 | -142 | -129 | -10 | -180 | -202 | -92 | -93 | |
Net Cash Flow Net Cash FlowCr | 4 | 11 | 1 | -8 | 10 | 1 | 7 | -14 | 2 | 26 | -3 |
Free Cash Flow Free Cash FlowCr | -130 | 130 | 114 | 70 | 247 | 148 | 35 | 47 | 151 | 227 | 40 |
CFO To PAT CFO To PAT% | 103.3 | 81.9 | 86.4 | 66.2 | 104.4 | 68.8 | 74.8 | 79.9 | 72.4 | 119.0 | 71.2 |
CFO To EBITDA CFO To EBITDA% | 76.2 | 63.5 | 66.1 | 48.7 | 85.5 | 62.0 | 63.7 | 61.7 | 65.2 | 97.8 | 57.9 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 174 | 154 | 150 | 112 | 250 | 207 | 162 | 155 | 221 | 318 | 200 | |
| -73 | -144 | 20 | -120 | -98 | -77 | -145 | 11 | -17 | -200 | -110 | |
| -97 | 0 | -169 | 0 | -142 | -129 | -10 | -180 | -202 | -92 | -93 | |
Net Cash Flow Net Cash FlowCr | 4 | 11 | 1 | -8 | 10 | 1 | 7 | -14 | 2 | 26 | -3 |
Free Cash Flow Free Cash FlowCr | -130 | 130 | 114 | 70 | 247 | 148 | 35 | 47 | 151 | 227 | 40 |
CFO To PAT CFO To PAT% | 103.3 | 81.9 | 86.4 | 66.2 | 104.4 | 68.8 | 74.8 | 79.9 | 72.4 | 119.0 | 71.2 |
CFO To EBITDA CFO To EBITDA% | 76.2 | 63.5 | 66.1 | 48.7 | 85.5 | 62.0 | 63.7 | 61.7 | 65.2 | 97.8 | 57.9 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 3,294 | 3,629 | 4,476 | 2,921 | 3,350 | 4,823 | 4,337 | 4,256 | 6,912 | 6,420 | 5,229 | 6,147 |
Price To Earnings Price To Earnings | 19.6 | 19.4 | 25.4 | 17.3 | 14.0 | 16.0 | 20.0 | 21.9 | 22.6 | 24.1 | 18.6 | 19.6 |
Price To Sales Price To Sales | 3.3 | 3.6 | 4.2 | 2.7 | 2.5 | 3.6 | 2.8 | 2.4 | 3.6 | 3.0 | 2.4 | 2.7 |
Price To Book Price To Book | 3.1 | 2.9 | 3.5 | 2.0 | 2.2 | 2.8 | 2.2 | 2.1 | 3.3 | 2.8 | 2.1 | 2.3 |
EV To EBITDA EV To EBITDA | 14.3 | 14.8 | 19.6 | 12.6 | 11.4 | 14.4 | 17.1 | 17.0 | 20.4 | 19.7 | 15.0 | 16.7 |
GPM GPM% | 56.8 | 58.4 | 58.2 | 58.7 | 60.1 | 60.5 | 56.0 | 53.6 | 56.4 | 55.8 | 57.6 | 57.6 |
OPM OPM% | 23.0 | 24.0 | 21.1 | 21.2 | 21.8 | 25.1 | 16.6 | 14.1 | 17.4 | 15.4 | 15.9 | 16.0 |
NPM NPM% | 17.0 | 18.6 | 16.1 | 15.6 | 17.9 | 22.6 | 14.2 | 10.9 | 15.7 | 12.7 | 13.0 | 13.7 |
ROCE ROCE% | 21.6 | 19.9 | 19.0 | 16.5 | 20.7 | 22.4 | 14.7 | 13.0 | 18.9 | 15.7 | 15.2 | 15.8 |
ROE ROE% | 15.6 | 14.8 | 13.6 | 11.8 | 15.5 | 17.4 | 11.1 | 9.8 | 14.6 | 11.7 | 11.3 | 11.7 |
ROA ROA% | 13.3 | 12.8 | 11.5 | 10.3 | 13.2 | 15.4 | 9.5 | 8.3 | 12.4 | 9.8 | 9.6 | 9.9 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 3,294 | 3,629 | 4,476 | 2,921 | 3,350 | 4,823 | 4,337 | 4,256 | 6,912 | 6,420 | 5,229 | 6,147 |
Price To Earnings Price To Earnings | 19.6 | 19.4 | 25.4 | 17.3 | 14.0 | 16.0 | 20.0 | 21.9 | 22.6 | 24.1 | 18.6 | 19.6 |
Price To Sales Price To Sales | 3.3 | 3.6 | 4.2 | 2.7 | 2.5 | 3.6 | 2.8 | 2.4 | 3.6 | 3.0 | 2.4 | 2.7 |
Price To Book Price To Book | 3.1 | 2.9 | 3.5 | 2.0 | 2.2 | 2.8 | 2.2 | 2.1 | 3.3 | 2.8 | 2.1 | 2.3 |
EV To EBITDA EV To EBITDA | 14.3 | 14.8 | 19.6 | 12.6 | 11.4 | 14.4 | 17.1 | 17.0 | 20.4 | 19.7 | 15.0 | 16.7 |
GPM GPM% | 56.8 | 58.4 | 58.2 | 58.7 | 60.1 | 60.5 | 56.0 | 53.6 | 56.4 | 55.8 | 57.6 | 57.6 |
OPM OPM% | 23.0 | 24.0 | 21.1 | 21.2 | 21.8 | 25.1 | 16.6 | 14.1 | 17.4 | 15.4 | 15.9 | 16.0 |
NPM NPM% | 17.0 | 18.6 | 16.1 | 15.6 | 17.9 | 22.6 | 14.2 | 10.9 | 15.7 | 12.7 | 13.0 | 13.7 |
ROCE ROCE% | 21.6 | 19.9 | 19.0 | 16.5 | 20.7 | 22.4 | 14.7 | 13.0 | 18.9 | 15.7 | 15.2 | 15.8 |
ROE ROE% | 15.6 | 14.8 | 13.6 | 11.8 | 15.5 | 17.4 | 11.1 | 9.8 | 14.6 | 11.7 | 11.3 | 11.7 |
ROA ROA% | 13.3 | 12.8 | 11.5 | 10.3 | 13.2 | 15.4 | 9.5 | 8.3 | 12.4 | 9.8 | 9.6 | 9.9 |
| Market CapitalizationMkt CapCr | 8,917 | 7,612 | 6,814 | 6,147 | 5,024 | 4,284 | 4,202 |
| Close PriceClose₹ | 967.30 | 269.40 | 640.55 | 377.55 | 1,090.80 | 4,128.40 | 2,540.90 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 14.46 | 42.09 | 19.62 | 35.52 | 44.67 | 37.91 | |
| Price To SalesPS | 1.71 | 836.51 | 6.34 | 2.69 | 6.99 | 6.86 | 5.50 |
| RevenueRevenueCr | 5,213 | 9 | 1,074 | 2,289 | 719 | 624 | 764 |
| Revenue Growth TTMRev Gr TTM% | 11.3% | 55.0% | 24.9% | 10.2% | 39.0% | 47.7% | 14.7% |
| PAT Growth TTMPAT Gr TTM% | 54.3% | -80.3% | 44.3% | 39.0% | 60.2% | 95.7% | -48.5% |
| Market CapitalizationMkt CapCr | 8,917 | 7,612 | 6,814 | 6,147 | 5,024 | 4,284 | 4,202 |
| Close PriceClose₹ | 967.30 | 269.40 | 640.55 | 377.55 | 1,090.80 | 4,128.40 | 2,540.90 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 14.46 | 42.09 | 19.62 | 35.52 | 44.67 | 37.91 | |
| Price To SalesPS | 1.71 | 836.51 | 6.34 | 2.69 | 6.99 | 6.86 | 5.50 |
| RevenueRevenueCr | 5,213 | 9 | 1,074 | 2,289 | 719 | 624 | 764 |
| Revenue Growth TTMRev Gr TTM% | 11.3% | 55.0% | 24.9% | 10.2% | 39.0% | 47.7% | 14.7% |
| PAT Growth TTMPAT Gr TTM% | 54.3% | -80.3% | 44.3% | 39.0% | 60.2% | 95.7% | -48.5% |